ScoreWhy is Fujian Wanchen Biotechnology Group Co., Ltd. ?
1
With a growth in Operating Profit of 228.9%, the company declared Outstanding results in Mar 25
- The company has declared positive results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 1,286.88 MM
- NET SALES(Q) At CNY 10,793.17 MM has Grown at 123.95%
- PRE-TAX PROFIT(Q) At CNY 523.61 MM has Grown at 362.85%
2
With ROE of 81.98%, it has a expensive valuation with a 16.17 Price to Book Value
- Over the past year, while the stock has generated a return of 148.17%, its profits have risen by 2287% ; the PEG ratio of the company is 0
3
Consistent Returns over the last 3 years
- Along with generating 148.17% returns in the last 1 year, the stock has outperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Fujian Wanchen Biotechnology Group Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Other Agricultural Products should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Fujian Wanchen Biotechnology Group Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Fujian Wanchen Biotechnology Group Co., Ltd.
134.47%
10.93
64.26%
China Shanghai Composite
15.19%
1.01
15.10%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
233.73%
EBIT Growth (5y)
293.10%
EBIT to Interest (avg)
9.86
Debt to EBITDA (avg)
0.40
Net Debt to Equity (avg)
-1.12
Sales to Capital Employed (avg)
8.16
Tax Ratio
36.09%
Dividend Payout Ratio
35.00%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.42%
ROE (avg)
20.88%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
16.17
EV to EBIT
12.84
EV to EBITDA
11.12
EV to Capital Employed
-69.30
EV to Sales
0.55
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
81.98%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend47What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 1,286.88 MM
NET SALES(Q)
At CNY 10,793.17 MM has Grown at 123.95%
PRE-TAX PROFIT(Q)
At CNY 523.61 MM has Grown at 362.85%
ROCE(HY)
Highest at 45.95%
DEBTORS TURNOVER RATIO(HY)
Highest at 391.74%
OPERATING PROFIT(Q)
Highest at CNY 527.04 MM
OPERATING PROFIT MARGIN(Q)
Highest at 4.88 %
RAW MATERIAL COST(Y)
Fallen by -22.38% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -90.81 %
INVENTORY TURNOVER RATIO(HY)
Highest at 31.93%
NET PROFIT(Q)
Highest at CNY 214.85 MM
EPS(Q)
Highest at CNY 1.19
-12What is not working for the Company
INTEREST(Q)
Highest at CNY 17.23 MM
Here's what is working for Fujian Wanchen Biotechnology Group Co., Ltd.
Net Sales
At CNY 10,793.17 MM has Grown at 123.95%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely positive
Net Sales (CNY MM)
Pre-Tax Profit
At CNY 523.61 MM has Grown at 362.85%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 214.85 MM has Grown at 3,344.13%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Operating Cash Flow
Highest at CNY 1,286.88 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Operating Profit
Highest at CNY 527.04 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (CNY MM)
Operating Profit Margin
Highest at 4.88 % and Grown
In each period in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at CNY 523.61 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Debtors Turnover Ratio
Highest at 391.74% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Net Profit
Highest at CNY 214.85 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 1.19
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Debt-Equity Ratio
Lowest at -90.81 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 31.93%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -22.38% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Fujian Wanchen Biotechnology Group Co., Ltd.
Interest
At CNY 17.23 MM has Grown at 22.93%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Interest
Highest at CNY 17.23 MM
in the last five periods and Increased by 22.93% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
